Atom | Gram-Negative Antibiotic Discovery Innovator (Gr-ADI)

Due Dates: June 30, 2025 (Notification of full proposal invitation)

Funding Amounts: Up to $5,000,000 USD per project for up to 3 years; exploratory projects with lower budgets and shorter durations are encouraged.

Summary: Supports early-stage discovery of broad-spectrum, direct-acting small molecule antibiotics against Enterobacteriaceae (using Klebsiella spp.) to address antimicrobial resistance.

Key Information: Applicants must agree to consortium-wide data sharing and be able to accept the terms of at least one of the three funders (Gates Foundation, Wellcome, NNF).

Gram-Negative Antibiotic Discovery Innovator (Gr-ADI)

Sign in to see full grant listing